Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05597410

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,418 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

The goal of this cohort study is to estimate the incidence of AD in the first-degree relatives of patients with AD. The main questions it aims to answer are: * cognitive changes of subjects at high risk of AD as ageing; * environmental and behavioral factors affecting AD incidence.

Detailed description

This study is a prospective cohort study focusing on the first-degree relatives of patients with Alzheimer's disease (AD). Multiple methods including the neuropsychiatric assessment battery, magnetic resonance imaging (MRI) and fluid biomarkers (blood and urine) are used to estimate the longitudinal changes of the participants at high risk of AD. Besides, a structured questionnaire is designed to investigate how environmental, behavioral and other factors influence the incidence of AD. This study is of great significance in establishing novel guidelines for the prevention and treatment of dementia suitable for Chinese population, and for clinicians to predict the risk of AD in first-degree relatives.

Conditions

Timeline

Start date
2022-03-01
Primary completion
2029-03-01
Completion
2030-03-01
First posted
2022-10-28
Last updated
2022-10-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05597410. Inclusion in this directory is not an endorsement.